drugset / Trial / NCT06287528
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Non-randomizedSequentialOpen-labelTreatment
Summary
Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sent to a laboratory to be changed (modified) to become 19-28z/IL-18, the CAR T-cell therapy that participants will receive during the study. Making the participants' study therapy will take about 2-4 weeks.
Timeline
- Start
- 2024-02-23
- Primary completion
- 2028-02-23
- Completion
- 2028-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 19-28z/IL-18 CAR T cells | Cell therapy | 500000 cells/kg | — |
| Subject | 19-28z/IL-18 CAR T cells | Cell therapy | 1e+06 cells/kg | — |